NYSE - Delayed Quote USD
Stevanato Group S.p.A. (STVN)
23.99
-0.33
(-1.36%)
At close: May 21 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,124,638
1,104,036
1,085,354
983,680
843,920
Cost of Revenue
814,624
801,717
745,461
663,879
578,515
Gross Profit
310,013
302,319
339,893
319,801
265,405
Operating Expense
139,533
141,177
139,173
127,370
103,180
Operating Income
170,480
161,142
200,720
192,431
162,225
Net Non Operating Interest Income Expense
-5,579
-5,838
-3,731
-3,404
-4,378
Other Income Expense
4,818
4,984
-7,436
-1,386
7,826
Pretax Income
169,721
160,288
189,553
187,641
165,673
Tax Provision
44,253
42,522
43,863
44,625
31,404
Net Income Common Stockholders
125,481
117,778
145,631
142,849
134,321
Diluted NI Available to Com Stockholders
125,481
117,778
145,631
142,849
134,321
Basic EPS
0.46
0.43
0.55
0.54
0.53
Diluted EPS
0.46
0.43
0.55
0.54
0.53
Basic Average Shares
272,873.75
271,136.20
264,951.37
264,700
252,700
Diluted Average Shares
272,884.93
271,152.50
264,977.55
264,700
252,700
Total Operating Income as Reported
170,480
161,142
200,720
192,431
162,225
Total Expenses
954,157
942,894
884,634
791,249
681,695
Net Income from Continuing & Discontinued Operation
125,481
117,778
145,631
142,849
134,321
Normalized Income
121,919.24
114,114.76
151,349.28
143,905.13
128,425.01
Interest Income
1,948
1,723
792
648
548
Interest Expense
6,761
6,864
4,315
3,936
4,871
Net Interest Income
-5,579
-5,838
-3,731
-3,404
-4,378
EBIT
176,482
167,152
193,868
191,577
170,544
EBITDA
256,093
247,804
272,348
256,400
226,926
Reconciled Cost of Revenue
814,624
801,717
745,461
663,879
578,515
Reconciled Depreciation
79,611
80,652
78,480
64,823
56,382
Net Income from Continuing Operation Net Minority Interest
125,481
117,778
145,631
142,849
134,321
Total Unusual Items Excluding Goodwill
4,818
4,984
-7,436
-1,386
7,279
Total Unusual Items
4,818
4,984
-7,436
-1,386
7,279
Normalized EBITDA
251,275
242,820
279,784
257,786
219,647
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,256.24
1,320.76
-1,717.72
-329.87
1,383.01
12/31/2021 - 7/16/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ICUI ICU Medical, Inc.
130.75
-3.09%
AVTR Avantor, Inc.
12.55
-6.83%
KMTS Kestra Medical Technologies, Ltd.
23.09
-7.34%
ANGO AngioDynamics, Inc.
9.57
+0.63%
NVST Envista Holdings Corporation
16.64
-6.36%
UTMD Utah Medical Products, Inc.
53.32
-1.66%
TFX Teleflex Incorporated
121.97
-3.85%
RGEN Repligen Corporation
120.21
-5.78%
1SXP.DE SCHOTT Pharma AG & Co. KGaA
29.35
-1.68%
ATR AptarGroup, Inc.
156.45
-1.31%